Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−30.08MXN
−4.33 BMXN
10.51 BMXN
100.14 M
About 10x Genomics, Inc.
Sector
Industry
CEO
Serge Saxonov
Website
Headquarters
Pleasanton
Founded
2012
FIGI
BBG00Z6QRNZ0
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange 10X GENOMICS, INC stocks are traded under the ticker TXG.
TXG stock has fallen by −0.25% compared to the previous week, the month change is a −0.25% fall, over the last year 10X GENOMICS, INC has showed a −0.25% decrease.
We've gathered analysts' opinions on 10X GENOMICS, INC future price: according to them, TXG price has a max estimate of 605.45 MXN and a min estimate of 282.54 MXN. Watch TXG chart and read a more detailed 10X GENOMICS, INC stock forecast: see what analysts think of 10X GENOMICS, INC and suggest that you do with its stocks.
TXG stock is 0.25% volatile and has beta coefficient of 1.52. Track 10X GENOMICS, INC stock price on the chart and check out the list of the most volatile stocks — is 10X GENOMICS, INC there?
Today 10X GENOMICS, INC has the market capitalization of 40.13 B, it has decreased by −1.27% over the last week.
Yes, you can track 10X GENOMICS, INC financials in yearly and quarterly reports right on TradingView.
10X GENOMICS, INC is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
TXG earnings for the last quarter are −5.91 MXN per share, whereas the estimation was −6.48 MXN resulting in a 8.72% surprise. The estimated earnings for the next quarter are −5.92 MXN per share. See more details about 10X GENOMICS, INC earnings.
10X GENOMICS, INC revenue for the last quarter amounts to 2.99 B MXN, despite the estimated figure of 3.09 B MXN. In the next quarter, revenue is expected to reach 3.11 B MXN.
TXG net income for the last quarter is −704.46 M MXN, while the quarter before that showed −695.10 M MXN of net income which accounts for −1.35% change. Track more 10X GENOMICS, INC financial stats to get the full picture.
No, TXG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 1.26 K employees. See our rating of the largest employees — is 10X GENOMICS, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 10X GENOMICS, INC EBITDA is −2.63 B MXN, and current EBITDA margin is −25.58%. See more stats in 10X GENOMICS, INC financial statements.
Like other stocks, TXG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 10X GENOMICS, INC stock right from TradingView charts — choose your broker and connect to your account.